Cytosine
|
Basic information |
| Metabolite name | Cytosine |
 | HMDB0000630 |
 |
C00380 |
 |
597 |
| Synonyms | NA |
| No. of studies | 12 |
|
Basic information |
| Metabolite name | Cytosine |
| HMDB0000630 |
|
C00380 |
|
597 |
| Synonyms | NA |
| No. of studies | 12 |
|
Relationship between Cytosine and depression (count: 12) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Up |
| Study M089 | Type3 | fluoxetine vs. control group | Fibroblast | Rhesus monkey | Down |
| Study M1055 | Type1 | depression group vs. control group | Urine | Human | Down |
| Study M130 | Type2 | CSDS + venlafaxine group vs. CSDS group | Prefrontal cortex | C57BL/6 mouse | Down |
| Study M539 | Type2 | LPS+ Dl-3-n-butylphthalide group vs. LPS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M693 | Type1 | SDS group vs. control group | Plasma | C57BL/6J mouse | Down |
| Study M712 | Type1 | depression group vs. control group | Intestine | Cynomolgus monkey | Up |
| Study M783 | Type1 | stroke + CUMS group vs. stroke group | Faece | Sprague-Dawley rat | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |
| Study M924 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Down |
| Study M924 | Type2 | CUMS + aerobic exercise group vs. CUMS group | Serum | Sprague-Dawley rat | Up |
| Study M927 | Type1 | CUMS group vs. control group | Brain | Sprague-Dawley rat | Down |
| Study M927 | Type2 | CUMS + Zhi-zi-chi decoction group vs. CUMS group | Brain | Sprague-Dawley rat | Up |
| Study M953 | Type2 | CRS + Shugan Granule group vs. CRS group | Faece | Sprague-Dawley rat | Up |